Twitter | Search | |
AASLD
AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease.
15,149
Tweets
2,940
Following
14,441
Followers
Tweets
AASLD 9h
From AASLD News: "A Troika of Updates." This month’s column follows up on some recent information that we have passed on with new developments of interest. Read it here.
Reply Retweet Like
AASLD 12h
From : "The role of senescence in the development of non‐alcoholic fatty liver disease and progression to non‐alcoholic steatohepatitis"
Reply Retweet Like
AASLD 12h
Congratulations! And those cookies look tasty!
Reply Retweet Like
AASLD retweeted
Nevzorova lab 13h
The first MS degree awarded to my first MS in Feelings so proud of my girl!! 👩🏻‍🎓👩🏻‍🔬Now, time for liver cookies,(well healthy liver and NAFLD liver cookies 🍪😊). We go to celebrate 🎉
Reply Retweet Like
AASLD retweeted
LTxJournal 17h
New study from UCSF shows that the Liver Frailty Index is valid in noncirrhotics and is highly reproducible:
Reply Retweet Like
AASLD 15h
REGISTRATION is open for the "Early Liver Transplantation in Alcoholic Hepatitis" webinar scheduled for Wednesday, July 24 at 9 am ET. Alexandre Louvet, MD, PhD is presenting. Register today.
Reply Retweet Like
AASLD retweeted
AnnalsSurgOncology Jun 21
. Analysis of results from large Western series of actual 10-year survivors after resection of .
Reply Retweet Like
AASLD 16h
Replying to @PLRC_PittLiver
Congratulations!
Reply Retweet Like
AASLD retweeted
PLRC 16h
Dr. James Squires has received the Autoimmune Liver Disease Pilot Research Award from AASLD for his project titled, "A Learning Health System for Pediatric Autoimmune Liver Disease Through Partnership with ImproveCareNow." Congratulations!
Reply Retweet Like
AASLD 17h
Join in putting the United States on a path toward ! Find people like you that are working toward elimination & learn how they did it so you can be part of the Map!
Reply Retweet Like
AASLD retweeted
Elliot Tapper 20h
Wake up call: Even when the Maddrey Score is <32, alc hep is really bad 👉6% mortality at 28 days 👉13% mortality at 1 year We need better addiction services and treatments
Reply Retweet Like
AASLD 18h
Congratulations!
Reply Retweet Like
AASLD retweeted
Juan Pablo Arab 20h
Congratulations to all recipients of 2019 awards! Including the best of the best and my personal friends Dr Eni and Dr Nidhi ! So proud of you!
Reply Retweet Like
AASLD retweeted
Jorge Bezerra Jun 25
Inspirational story and perspective on Taka Takebe’s strategy to develop human liver buds or to model diseases and meet the needs or failing organs
Reply Retweet Like
AASLD Jun 25
REGISTER for the "Challenges in Antiviral Therapy for " webinar scheduled for Tuesday, July 23 at 1:00 pm ET. Brian Pearlman, MD is moderating & presenting. Register today.
Reply Retweet Like
AASLD Jun 25
From : A Multi-institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma
Reply Retweet Like
AASLD Jun 25
To renew your AASLD membership by June 30, visit
Reply Retweet Like
AASLD retweeted
AASLD Foundation Jun 25
Check out 2018 AASLD Foundation Awardee Serkan Belkaya’s latest research in : "Inherited IL-18BP deficiency in human fulminant viral hepatitis"
Reply Retweet Like
AASLD retweeted
William Sanchez, MD, AGAF, FAASLD Jun 24
Fantastic to see great research efforts being recognized. Congrats to all!
Reply Retweet Like
AASLD Jun 25
Meet the 2019 Research and Career Development Awards recipients.
Reply Retweet Like